Literature DB >> 1340213

Control of transforming growth factor-beta activity: latency vs. activation.

J G Harpel1, C N Metz, S Kojima, D B Rifkin.   

Abstract

Transforming growth factor-beta is a pluripotent regulator of cell growth and differentiation. The growth factor is expressed as a latent complex that must be converted to an active form before interacting with its ubiquitous high affinity receptors. This conversion involves the release of the mature growth factor through disruption of the non-covalent interactions with its pro-peptide or latency associated peptide. The mechanisms for this release in vivo have not been fully characterized but appear to be cell specific and might involve processes such as acidification or proteolysis. Although several factors including transcriptional regulation, receptor modulation and scavenging of the active growth factor have been implicated, the critical step controlling the biological effects of transforming growth factor-beta may be the activation of the latent molecule.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1340213     DOI: 10.1016/0955-2235(92)90014-9

Source DB:  PubMed          Journal:  Prog Growth Factor Res        ISSN: 0955-2235


  11 in total

1.  Active transforming growth factor-beta in wound repair: determination using a new assay.

Authors:  L Yang; C X Qiu; A Ludlow; M W Ferguson; G Brunner
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

2.  MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily.

Authors:  M R Bootcov; A R Bauskin; S M Valenzuela; A G Moore; M Bansal; X Y He; H P Zhang; M Donnellan; S Mahler; K Pryor; B J Walsh; R C Nicholson; W D Fairlie; S B Por; J M Robbins; S N Breit
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

3.  Circulating transforming growth factor beta 1 (TGF-beta1) in Guillain-Barré syndrome: decreased concentrations in the early course and increase with motor function.

Authors:  A Créange; L Bélec; B Clair; J D Degos; J C Raphaël; R K Gherardi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-02       Impact factor: 10.154

4.  TGF-beta receptor expression in human odontoblasts and pulpal cells.

Authors:  A J Sloan; J B Matthews; A J Smith
Journal:  Histochem J       Date:  1999-08

5.  Role of transforming growth factor beta-1 in peritonitis-induced adhesions.

Authors:  A M Ghellai; A F Stucchi; N Chegini; C Ma; C D Andry; J M Kaseta; J W Burns; K C Skinner; J M Becker
Journal:  J Gastrointest Surg       Date:  2000 May-Jun       Impact factor: 3.452

6.  Antisense oligonucleotides against thrombospondin-1 inhibit activation of tgf-beta in fibrotic renal disease in the rat in vivo.

Authors:  Christoph Daniel; Yoshitugu Takabatake; Masayuki Mizui; Yoshitaka Isaka; Hiroshi Kawashi; Harald Rupprecht; Enyu Imai; Christian Hugo
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

7.  Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta.

Authors:  I Nunes; P E Gleizes; C N Metz; D B Rifkin
Journal:  J Cell Biol       Date:  1997-03-10       Impact factor: 10.539

8.  Cytokines as cellular communicators.

Authors:  R Debets; H F Savelkoul
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

9.  Transforming growth factor beta 1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients.

Authors:  H Robson; E Anderson; R D James; P F Schofield
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

Review 10.  Controversy surrounding the increased expression of TGF beta 1 in asthma.

Authors:  Ynuk Bossé; Marek Rola-Pleszczynski
Journal:  Respir Res       Date:  2007-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.